Tuesday, May 27, 2014

Question of the Day May 27, 2014 So far every compounding pharmacy that has registered with the FDA as an outsourcing facility that the FDA has inspected has had a 483 issued showing problems with the compounding pharmacy. What does this tell the public? The compounding pharmacies all have room for improvement? The FDA is being too tough? None of the compounding pharmacies with outstanding compliance have registered or are willing to register? Will those inspected by the FDA bringing their "outsourcing facilities" in compliance with the DQSA? It just a question of knowing what is expected and then the outsourcers will fix what needs to be fixed?

view list of FDA registered outsourcing facilities and 483s  here

No comments: